06. December 2017

The US FDA and EMA recently issued industry guidance focused on reducing risk associated with medication errors and improving patient compliance. Recommendations are that varying color, shape, and size between dose strengths of a solid oral medication are useful tools to improve diff erentiation and minimize potential for errors. Additionally, visual differentiation of immediate and modifi ed release dosage forms of the same drug is essential to ensure overall patient safety.